Coagulation Factor XIII Val34Leu Polymorphism in the Prediction of Premature Cardiovascular Events—The Results of Two Meta-Analyses
Background: Polymorphisms within the gene that encodes for coagulation factor XIII (FXIII) have been suggested to be involved in the pathogeneses of ischemic stroke (IS) and myocardial infarction (MI). The Val34Leu polymorphism is one of the most commonly analysed <i>FXIII</i> polymorphi...
Main Authors: | Beata Sarecka-Hujar, Danuta Łoboda, Elżbieta Paradowska-Nowakowska, Krzysztof S. Gołba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/12/3454 |
Similar Items
-
Congenital factor XIII deficiency in Switzerland: From the worldwide first case in 1960 to its molecular characterisation in 2005
by: V Schroeder, et al.
Published: (2007-05-01) -
Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery
by: Gianluca Sottilotta, et al.
Published: (2019-02-01) -
Long COVID-19 Syndrome Severity According to Sex, Time from the Onset of the Disease, and Exercise Capacity—The Results of a Cross-Sectional Study
by: Elżbieta Paradowska-Nowakowska, et al.
Published: (2023-02-01) -
Factor XIII deficiency in the Saudi population, an underestimated bleeding risk. Review article and an illustrative case report with dental complications
by: Mansour Aljabry
Published: (2023-05-01) -
Role of blood coagulation factor XIII in vascular diseases
by: Swiss Medical Weekly
Published: (2001-01-01)